申请人:Cottrell Kevin M.
公开号:US20100330109A1
公开(公告)日:2010-12-30
The present invention relates to compounds of formula I:
or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection and to processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.
本发明涉及公式I的化合物,或其药学上可接受的盐或混合物,其能够抑制丝氨酸蛋白酶活性,特别是丙型肝炎病毒NS3-NS4A蛋白酶的活性。因此,它们通过干扰丙型肝炎病毒的生命周期来发挥作用,并且也可用作抗病毒药物。本发明进一步涉及包含这些化合物的组合物,无论是用于体外使用还是用于治疗患有HCV感染的患者的给药,以及制备这些化合物的过程。本发明还涉及通过给予本发明化合物组成的组合物治疗患者的HCV感染的方法。本发明还涉及制备这些化合物的过程。